Sara joins Vizgen Inc. from Advanced Instruments where she led Corporate Business Development, Scientific Applications, Biopharma Marketing and Product Management.  Here she played a key role in the transformation of the company with the development and execution of a strategy focused on the biopharma market segment and following that, the sale of the company for $780M, 24x EBITDA to Patricia Industries in 2020.  Post the sale of the company, Sara led the acquisition of Solentim and SAL Scientific, further pivoting the company and portfolio to high growth market segments.

Prior to this Sara has held various commercial leadership roles at companies such as ThermoFisher Scientific, PerkinElmer, Cell Signaling Technology and Bayer.

Sara earned a Bachelor of Science with honors degree in biomedical sciences from Bradford University, United Kingdom.